297 related articles for article (PubMed ID: 38398726)
21. Locoregional therapy for cholangiocarcinoma.
Kuhlmann JB; Blum HE
Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
[TBL] [Abstract][Full Text] [Related]
22. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
Bibok A; Kim DW; Malafa M; Kis B
World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
[TBL] [Abstract][Full Text] [Related]
24. Genetic/Epigenetic Alteration and Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Transforming the Immune Microenvironment with Molecular-Targeted Agents.
Nishida N; Kudo M
Liver Cancer; 2024 Apr; 13(2):136-149. PubMed ID: 38751556
[TBL] [Abstract][Full Text] [Related]
25. Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma.
Auer TA; Collettini F; Segger L; Pelzer U; Mohr R; Krenzien F; Gebauer B; Geisel D; Hosse C; Schöning W; Fehrenbach U
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174120
[TBL] [Abstract][Full Text] [Related]
26. Management of Intrahepatic Cholangiocarcinoma.
Kodali S; Shetty A; Shekhar S; Victor DW; Ghobrial RM
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072277
[TBL] [Abstract][Full Text] [Related]
27. Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?
Sun D; Lv G; Dong J
Front Oncol; 2021; 11():841694. PubMed ID: 35127541
[TBL] [Abstract][Full Text] [Related]
28. Cholangiocarcinoma - evolving concepts and therapeutic strategies.
Ilyas SI; Khan SA; Hallemeier CL; Kelley RK; Gores GJ
Nat Rev Clin Oncol; 2018 Feb; 15(2):95-111. PubMed ID: 28994423
[TBL] [Abstract][Full Text] [Related]
29. Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
Lee YT; Singal AG; Lauzon M; Agopian VG; Luu M; Noureddin M; Todo T; Kim IK; Friedman ML; Kosari K; Nissen NN; Roberts LR; Heimbach JK; Gores GJ; Yang JD
Cancer; 2022 Oct; 128(20):3610-3619. PubMed ID: 35997126
[TBL] [Abstract][Full Text] [Related]
30. New Options for Systemic Therapies in Intrahepatic Cholangiocarcinoma (iCCA).
Becht R; Wasilewicz MP
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374378
[TBL] [Abstract][Full Text] [Related]
31. The state of therapy modalities in clinic for biliary tract cancer.
Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
[TBL] [Abstract][Full Text] [Related]
32. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.
Ierardi AM; Angileri SA; Patella F; Panella S; Lucchina N; Petre EN; Pinto A; Franceschelli G; Carrafiello G; Cornalba G; Sofocleous CT
Med Oncol; 2017 Jan; 34(1):11. PubMed ID: 28008570
[TBL] [Abstract][Full Text] [Related]
33. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Sapisochin G; Ivanics T; Heimbach J
Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
[TBL] [Abstract][Full Text] [Related]
34. Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status.
Qian K; Zhang F; Allison SK; Zheng C; Yang X
J Interv Med; 2021 Feb; 4(1):1-7. PubMed ID: 34805939
[TBL] [Abstract][Full Text] [Related]
35. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.
Renzulli M; Ramai D; Singh J; Sinha S; Brandi N; Ierardi AM; Albertini E; Sacco R; Facciorusso A; Golfieri R
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283065
[TBL] [Abstract][Full Text] [Related]
36. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.
Cristinziano G; Porru M; Lamberti D; Buglioni S; Rollo F; Amoreo CA; Manni I; Giannarelli D; Cristofoletti C; Russo G; Borad MJ; Grazi GL; Diodoro MG; Giordano S; Sacconi A; Forcato M; Anastasi S; Leonetti C; Segatto O
J Hepatol; 2021 Aug; 75(2):351-362. PubMed ID: 33741397
[TBL] [Abstract][Full Text] [Related]
37. Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?
Aitcheson G; Mahipal A; John BV
Expert Opin Investig Drugs; 2021 Apr; 30(4):463-477. PubMed ID: 33678096
[No Abstract] [Full Text] [Related]
38. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors.
Criss CR; Makary MS
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508428
[TBL] [Abstract][Full Text] [Related]
39. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
Wang Y; Strazzabosco M; Madoff DC
Curr Oncol Rep; 2022 Dec; 24(12):1741-1750. PubMed ID: 36255606
[TBL] [Abstract][Full Text] [Related]
40. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
Rana A; Hong JC
Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
